Menu
Menu
What’s the biggest challenge facing the cannabis industry right now, and how are you and/or your company addressing it?
Cannabis is not alcohol or a pharmaceutical drug; it’s a plant medicine. The general public has never been properly educated on medicines (or poisons) and plant medicines are complex. NAP focuses on making that knowledge more accessible, involving the community directly in prioritizing impactful scientific goals, and validating real-world observational lived experiences.
Where do you see the most exciting opportunity for growth and innovation in cannabis?
I think expanding and finding product types that are tailored to specific use cases is exciting. Being able to better predict the effects of specific products or strains for different subpopulations is also part of this.
What’s one piece of advice you would give to someone looking to break into the cannabis industry?
It’s both a rollercoaster and a marathon, so you better be having fun at the same time! Find something that inspires you and find people who feel the same way about it.
What is the most important thing you have learned from your experiences in the cannabis industry?
The only certainty in this industry is that it will continue to change at a rapid pace, but the medicine will always be the real value. This plant saves lives and access to medicine is a global health equity issue. Cannabis is so much more valuable as a medicine than its profitability as a vice or recreational experience.
What do you want your legacy to be as it relates to the cannabis industry?
I hope one day everyone can understand how much scientific validity there is behind the medicinal effects of cannabis, especially for the neurodivergent, queer, and otherwise atypical stoners.